{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:31:32Z","timestamp":1792373492960,"version":"4.4.0"},"reference-count":69,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2014.00134","type":"journal-article","created":{"date-parts":[[2014,3,31]],"date-time":"2014-03-31T09:02:02Z","timestamp":1396256522000},"source":"Crossref","is-referenced-by-count":55,"title":["Live Vaccination Tactics: Possible Approaches for Controlling Visceral Leishmaniasis"],"prefix":"10.3389","volume":"5","author":[{"given":"Noushin","family":"Saljoughian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahareh","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Rafati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,3,31]]},"reference":[{"issue":"3","key":"B1","first-page":"345","article-title":"Visceral leishmaniasis \u00e2\u20ac\u201c current therapeutic modalities","volume":"123","author":"Sundar","year":"2013","journal-title":"Indian J Med Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/j.1365-3156.2009.02306.x","article-title":"Cost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India","volume":"14","author":"Olliaro","year":"2009","journal-title":"Trop Med Int Health"},{"key":"B3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1365-3156.2008.02195.x","article-title":"Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India","volume":"14","author":"Olliaro","year":"2009","journal-title":"Trop Med Int Health"},{"key":"B4","first-page":"377","article-title":"Effectiveness of leishmanization in the control of cutaneous leishmaniasis","volume":"76","author":"Nadim","year":"1983","journal-title":"Bull Soc Pathol Exot Filiales"},{"key":"B5","first-page":"240","article-title":"Characterization of Leishmania isolated from unhealed lesions caused by leishmanization","volume":"11","author":"Hosseini","year":"2005","journal-title":"East Mediterr Health J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"6759","DOI":"10.1016\/j.vaccine.2008.09.085","article-title":"First generation leishmaniasis vaccines: a review of field efficacy trials","volume":"26","author":"Noazin","year":"2008","journal-title":"Vaccine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.1016\/j.vaccine.2009.05.084","article-title":"Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis: a meta-analysis","volume":"27","author":"Noazin","year":"2009","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.1128\/IAI.00394-07","article-title":"Leish-111f, a recombinant polyprotein vaccine that protects against visceral leishmaniasis by elicitation of CD4+ T cells","volume":"75","author":"Coler","year":"2007","journal-title":"Infect Immun"},{"key":"B9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nature03188","article-title":"Genetically modified Plasmodium parasites as a protective experimental malaria vaccine","volume":"433","author":"Mueller","year":"2005","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.02.055","article-title":"Immunization with genetically attenuated P. falciparum parasites induces long-lived antibodies that efficiently block hepatocyte invasion by sporozoites","author":"Finney","year":"2014","journal-title":"Vaccine"},{"key":"B11","first-page":"244","volume-title":"Lizard Leishmania. Biology of the Kinetoplastida","author":"Wilson","year":"1978"},{"key":"B12","doi-asserted-by":"publisher","first-page":"6372","DOI":"10.1128\/IAI.73.10.6372-6382.2005","article-title":"Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis","volume":"73","author":"Breton","year":"2005","journal-title":"Infect Immun"},{"key":"B13","first-page":"218","article-title":"Observations on immunization against cutaneous leishmaniasis in Israel","volume":"14","author":"Koufman","year":"1978","journal-title":"Isr J Med Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1016\/j.vaccine.2005.02.015","article-title":"Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis","volume":"23","author":"Khamesipour","year":"2005","journal-title":"Vaccine"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1128\/IAI.73.8.4714-4722.2005","article-title":"Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection","volume":"73","author":"Tabbara","year":"2005","journal-title":"Infect Immun"},{"issue":"Pt 2","key":"B16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/icb.1984.14","article-title":"Vaccination against cutaneous leishmaniasis in mice using nonpathogenic cloned promastigotes of Leishmania major and importance of route of injection","volume":"62","author":"Mitchell","year":"1984","journal-title":"Aust J Exp Biol Med Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0008-8749(85)90081-4","article-title":"Immunization of susceptible BALB\/c mice against Leishmania braziliensis. II. Use of temperature-sensitive avirulent clones of parasite for vaccination purposes","volume":"94","author":"Gorczynski","year":"1985","journal-title":"Cell Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-3024.1993.tb00587.x","article-title":"Vaccine development against cutaneous leishmaniasis. Subcutaneous administration of radioattenuated parasites protects CBA mice against virulent Leishmania major challenge","volume":"15","author":"Rivier","year":"1993","journal-title":"Parasite Immunol"},{"key":"B19","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1128\/IAI.61.12.5205-5213.1993","article-title":"An avirulent lipophosphoglycan-deficient Leishmania major clone induces CD4+ T cells which protect susceptible BALB\/c mice against infection with virulent L. major","volume":"61","author":"Kimsey","year":"1993","journal-title":"Infect Immun"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1086\/374783","article-title":"Leishmania mexicana and Leishmania major: attenuation of wild-type parasites and vaccination with the attenuated lines","volume":"187","author":"Daneshvar","year":"2003","journal-title":"J Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"10267","DOI":"10.1073\/pnas.92.22.10267","article-title":"Development of a safe live Leishmania vaccine line by gene replacement","volume":"92","author":"Titus","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1093\/emboj\/16.10.2590","article-title":"Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages","volume":"16","author":"Dumas","year":"1997","journal-title":"EMBO J"},{"key":"B23","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.1128\/MCB.17.10.5987","article-title":"Leishmania major Hsp100 is required chiefly in the mammalian stage of the parasite","volume":"17","author":"Hubel","year":"1997","journal-title":"Mol Cell Biol"},{"key":"B24","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.4049\/jimmunol.161.12.6794","article-title":"Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response","volume":"161","author":"Alexander","year":"1998","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1128\/IAI.70.1.62-68.2002","article-title":"Reduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination","volume":"70","author":"Papadopoulou","year":"2002","journal-title":"Infect Immun"},{"key":"B26","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.4049\/jimmunol.172.6.3793","article-title":"Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response","volume":"172","author":"Uzonna","year":"2004","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.4049\/jimmunol.179.5.3161","article-title":"SIR2-deficient Leishmania infantum induces a defined IFN-gamma\/IL-10 pattern that correlates with protection","volume":"179","author":"Silvestre","year":"2007","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/ni1162","article-title":"Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function","volume":"6","author":"Sporri","year":"2005","journal-title":"Nat Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.0105-2896.2006.00400.x","article-title":"Th1 memory: implications for vaccine development","volume":"211","author":"Foulds","year":"2006","journal-title":"Immunol Rev"},{"key":"B30","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.4049\/jimmunol.166.3.1921","article-title":"Protective immunity against the protozoan Leishmania chagasi is induced by subclinical cutaneous infection with virulent but not avirulent organisms","volume":"166","author":"Streit","year":"2001","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/00034983.1992.11812677","article-title":"Effects of long-term in vitro cultivation on the virulence of cloned lines of Leishmania major promastigotes","volume":"86","author":"Segovia","year":"1992","journal-title":"Ann Trop Med Parasitol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.actatropica.2010.04.007","article-title":"The influence of ecto-nucleotidases on Leishmania amazonensis infection and immune response in C57B\/6 mice","volume":"115","author":"de Souza","year":"2010","journal-title":"Acta Trop"},{"key":"B33","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/0035-9203(82)90232-2","article-title":"A radioattenuated Leishmania major vaccine markedly increases the resistance of CBA mice to subsequent infection with Leishmania mexicana mexicana","volume":"76","author":"Alexander","year":"1982","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"B34","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.0141-9838.2004.00671.x","article-title":"Leishmania mexicana H-line attenuated under pressure of gentamicin, potentiates a Th1 response and control of cutaneous leishmaniasis in BALB\/c mice","volume":"25","author":"Daneshvar","year":"2003","journal-title":"Parasite Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1017\/S0031182009990679","article-title":"Leishmania major H-line attenuated under pressure of gentamicin, induces a Th1 response which protects susceptible BALB\/c mice against infection with virulent L. major","volume":"136","author":"Daneshvar","year":"2009","journal-title":"Parasitology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.vetimm.2008.12.002","article-title":"Gentamicin-attenuated Leishmania infantum: a clinicopathological study in dogs","volume":"129","author":"Daneshvar","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/j.1365-3024.2010.01237.x","article-title":"Gentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis","volume":"32","author":"Daneshvar","year":"2010","journal-title":"Parasite Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1017\/S0031182012001187","article-title":"Alteration in mononuclear cell subpopulations in dogs immunized with gentamicin-attenuated Leishmania infantum","volume":"139","author":"Daneshvar","year":"2012","journal-title":"Parasitology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1590\/S0074-02762002000700019","article-title":"Study of the safety, immunogenicity and efficacy of attenuated and killed Leishmania (Leishmania) major vaccines in a rhesus monkey (Macaca mulatta) model of the human disease","volume":"97","author":"Amaral","year":"2002","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1016\/j.vaccine.2005.05.045","article-title":"Pathogenicity and protective immunogenicity of cysteine proteinase-deficient mutants of Leishmania mexicana in non-murine models","volume":"24","author":"Saravia","year":"2006","journal-title":"Vaccine"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1002\/eji.200838423","article-title":"Decreased IL-10 and IL-13 production and increased CD44hi T cell recruitment contribute to Leishmania major immunity induced by non-persistent parasites","volume":"38","author":"Kedzierski","year":"2008","journal-title":"Eur J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.4049\/jimmunol.0900276","article-title":"Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis","volume":"183","author":"Selvapandiyan","year":"2009","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1756-3305-4-150","article-title":"Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: a preliminary evaluation","volume":"4","author":"Carrion","year":"2011","journal-title":"Parasit Vectors"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.4049\/jimmunol.1202801","article-title":"Live attenuated Leishmania donovani p27 gene knockout parasites are nonpathogenic and elicit long-term protective immunity in BALB\/c mice","volume":"190","author":"Dey","year":"2013","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.vaccine.2013.01.048","article-title":"Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs","volume":"31","author":"Fiuza","year":"2013","journal-title":"Vaccine"},{"key":"B46","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1550-7408.1985.tb03015.x","article-title":"Effects of long-term in vitro cultivation on Leishmania donovani promastigotes","volume":"32","author":"Nolan","year":"1985","journal-title":"J Protozool"},{"key":"B47","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0014-4894(74)90019-8","article-title":"Leishmania enrietti: radiation effects and evaluation of radioattenuated organisms for vaccination","volume":"35","author":"Lemma","year":"1974","journal-title":"Exp Parasitol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"85","DOI":"10.7555\/JBR.27.20120064","article-title":"Development of Leishmania vaccines: predicting the future from past and present experience","volume":"27","author":"Mutiso","year":"2013","journal-title":"J Biomed Res"},{"key":"B49","first-page":"455","article-title":"Genetically modified live attenuated parasites as vaccines for leishmaniasis","volume":"123","author":"Selvapandiyan","year":"2006","journal-title":"Indian J Med Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"892817","DOI":"10.1155\/2012\/892817","article-title":"Development of vaccines against visceral leishmaniasis","volume":"2012","author":"Evans","year":"2012","journal-title":"J Trop Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"631460","DOI":"10.1155\/2012\/631460","article-title":"Immunity to visceral leishmaniasis using genetically defined live-attenuated parasites","volume":"2012","author":"Selvapandiyan","year":"2012","journal-title":"Re Dai Yi Xue Za Zhi"},{"key":"B52","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00005-008-0010-9","article-title":"Live attenuated Leishmania vaccines: a potential strategic alternative","volume":"56","author":"Silvestre","year":"2008","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B53","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0264-410X(98)90017-2","article-title":"Immunoprophylaxis and immunotherapy against experimental visceral leishmaniasis","volume":"17","author":"Mukhopadhyay","year":"1999","journal-title":"Vaccine"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1093\/nar\/25.21.4278","article-title":"Parameters controlling the rate of gene targeting frequency in the protozoan parasite Leishmania","volume":"25","author":"Papadopoulou","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"B55","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.4049\/jimmunol.145.7.2281","article-title":"Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis","volume":"145","author":"Yang","year":"1990","journal-title":"J Immunol"},{"key":"B56","first-page":"1","article-title":"Protection against Leishmania major infection in genetically susceptible BALB\/c mice by gp63 delivered orally in attenuated Salmonella typhimurium (AroA- AroD-)","volume":"85","author":"Xu","year":"1995","journal-title":"Immunology"},{"key":"B57","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.4049\/jimmunol.160.3.1285","article-title":"Protective effect on Leishmania major infection of migration inhibitory factor, TNF-alpha, and IFN-gamma administered orally via attenuated Salmonella typhimurium","volume":"160","author":"Xu","year":"1998","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S0264-410X(97)00267-3","article-title":"Immunogenicity of a Salmonella typhi CVD 908 candidate vaccine strain expressing the major surface protein gp63 of Leishmania mexicana mexicana","volume":"16","author":"Gonzalez","year":"1998","journal-title":"Vaccine"},{"key":"B59","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1128\/IAI.72.8.4924-4928.2004","article-title":"DNA-salmonella enterica serovar Typhimurium primer-booster vaccination biases towards T helper 1 responses and enhances protection against Leishmania major infection in mice","volume":"72","author":"Lange","year":"2004","journal-title":"Infect Immun"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e1406","DOI":"10.1371\/journal.pntd.0001406","article-title":"Single dose novel Salmonella vaccine enhances resistance against visceralizing L. major and L. donovani infection in susceptible BALB\/c mice","volume":"5","author":"Schroeder","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1099\/jmm.0.029959-0","article-title":"Generation and evaluation of A2-expressing Lactococcus lactis live vaccines against Leishmania donovani in BALB\/c mice","volume":"60","author":"Yam","year":"2011","journal-title":"J Med Microbiol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"5726","DOI":"10.1016\/j.vaccine.2012.07.004","article-title":"Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB\/c mice against Leishmania major infection","volume":"30","author":"Hugentobler","year":"2012","journal-title":"Vaccine"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e30945","DOI":"10.1371\/journal.pone.0030945","article-title":"Immunization against Leishmania major infection using LACK- and IL-12-expressing Lactococcus lactis induces delay in footpad swelling","volume":"7","author":"Hugentobler","year":"2012","journal-title":"PLoS One"},{"key":"B64","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.vaccine.2009.09.114","article-title":"Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis","volume":"28","author":"Mizbani","year":"2009","journal-title":"Vaccine"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e2174","DOI":"10.1371\/journal.pntd.0002174","article-title":"Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral Leishmaniasis","volume":"7","author":"Saljoughian","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"B66","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1365-3024.1987.tb00496.x","article-title":"Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system","volume":"9","author":"Dougan","year":"1987","journal-title":"Parasite Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1574-695X.2000.tb01450.x","article-title":"Recombinant live Salmonella spp. for human vaccination against heterologous pathogens","volume":"27","author":"Bumann","year":"2000","journal-title":"FEMS Immunol Med Micro"},{"key":"B68","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0022-1759(91)90298-T","article-title":"Live attenuated Salmonella vaccines and their potential as oral combined vaccines carrying heterologous antigens","volume":"142","author":"Hormaeche","year":"1991","journal-title":"J Immunol Methods"},{"key":"B69","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ijfoodmicro.2007.08.013","article-title":"Safety assessment of dairy microorganisms: the Lactococcus genus","volume":"126","author":"Casalta","year":"2008","journal-title":"Int J Food Microbiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T17:30:26Z","timestamp":1689096626000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2014.00134\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,31]]},"references-count":69,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2014.00134","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,31]]}}}